D/E 0.28 — less debt than most Industrials peers (≈25th pctile)
P/E31.5xB
P/E 31.5 — near the Industrials median (≈60th pctile)
PEG2.03C
PEG 2.03 — expensive relative to growth rate
Forward price target — the 1-year figure is the analyst consensus where the stock is covered; the 5- and 10-year figures compound our earnings estimate from there. The DCF below is a separate cross-check on intrinsic value (what it's worth today), not another target.
Quality-growth score · 73.7
Quality92.3
Growth84.0
Value51.7
Why this score
Buying back stock
Raising its dividend
Durable high returns
Entry · Margin of safety
52-week rangeMid-range
14% off the 12-month high
vs DCF fair value25% aboveest. fair value ~$56
What the price assumes: free cash flow compounding at ~14% a year for the next decade — vs the ~13% a year our model projects from current growth and analyst estimates.
Quality signals · context only
ROIC34.9% · Areturn on invested capital — not score-weighted
Model-generatedGenerated by the Bull Rankings model from this company's reported fundamentals, and checked against the figures shown above.
Why now
EXPO is a high-quality engineering consultancy compounder riding secular demand for safety, durability, and regulatory compliance in infrastructure, healthcare, and industrial systems. The company's 32.2% ROE and 18.1% profit margins prove pricing power in niche technical services where failure risk justifies premium fees, and the 7.8% revenue growth is accelerating despite macro headwinds. The crux: clients pay up for Exponent's deep expertise in biomechanics, corrosion engineering, and vehicle safety — domains where shortcuts are catastrophic and repeat business is sticky.
Moat
Exponent's moat is built on regulatory-driven demand for failure prevention in high-stakes systems, where its 18.1% profit margins reflect pricing power derived from category leadership in civil, biomedical, and materials engineering. Competitors can hire engineers, but they cannot replicate Exponent's decades of proprietary failure databases, litigation-tested methodologies, or the trust embedded in its brand among insurers and OEMs. Switching costs are high: clients rely on Exponent's certifications, historical data, and risk modeling to avoid liability — a moat that widens as industrial complexity and litigation exposure grow.
Risk
The bear case is that EXPO's P/E of 29.7x and PEG of 2.03 embed optimism that 7.8% revenue growth can sustain 12% FCF growth for a decade — a bet on unrelenting demand for niche engineering services. Skeptics point to its 0.28 debt-to-equity as a sign of balance-sheet prudence masking cyclical exposure to construction and automotive end-markets, where downturns could crater utilization. The concrete signal to sell: if revenue growth decelerates below 5% while margins compress below 15%, the model's implied growth assumption breaks and the premium multiple collapses.
Horizon
1-3 yr $84.00 (3-analyst consensus) — fundamentals + valuation re-rating. 5 yr $122.98 at ~12% CAGR — compounding case rests on the competitive position widening. 10 yr $182.44 if current growth sustains into durable earnings power.
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.
EXPO vs the Top Picks average
Pillar
EXPO
Book avg
Diff
Quality
0.92
0.84
+0.08
Growth
0.84
0.84
in line
Value
0.52
0.78
-0.27
Averaged across the 30 names in today's Top Picks (mean score 81.5). A name can beat these averages and still be absent from the book — it also applies concentration limits.
Score history · EXPO
Trend
+1.1 over 47 daily scores
From 72.6 (Jun 22) → 73.7 (now)
One point per daily model run. The range autoscales, so a flat-looking line can still hide 1–2 point moves — read the From → To values for the actual range.
Analyst estimate revisions
30-day change
+2.9%
90-day change
+2.9%
Forward EPS estimate
$2.84
Over the last 90 days, what analysts expect EXPO to earn is drifting higher (+2.9%). The estimate is derived from price and forward P/E captured at the same instant, so a moving share price does not move this number — only a changed forecast does.
A rising estimate means expectations are improving, not that the price has failed to keep up — and estimates get cut as readily as they get raised. It is not part of the Bull Rankings score. Biggest movers across the market →
Position sizing · EXPO
$
%
%
Shares to buy
28
Position size
$1,966
3.9% of portfolio
Stop price
$52.66
25% below $70.21
$ at risk if stopped
$491.47
budget $500.00 · 1% of portfolio
Math only — share count is floor(portfolio × risk% ÷ (price × stop%)). Doesn't account for commissions, slippage, gap risk, or position-correlation across your book. Inputs persist locally; never sent to the server. Not investment advice.
Exponent, Inc. (EXPO): score, valuation & FAQ
Exponent, Inc. (EXPO) is a Engineering & Construction company that scores 73.7 out of 100 on the Bull Rankings quality-growth model — a solid, above-average reading. The score blends three pillars — quality (durable returns, healthy margins, low leverage), growth (revenue and earnings), and value (valuation versus sector peers) — into one number, refreshed daily; it is a screen, not a buy recommendation.
Its strongest graded signals are D/E (A-) and Rev (B+). On valuation, EXPO sits about 25% above our discounted-cash-flow fair value — the current price implies roughly 14% annual free-cash-flow growth over the next decade.
Is EXPO a good stock to buy?
Bull Rankings scores EXPO 73.7 out of 100 on its quality-growth model, which is a solid, above-average reading. That is driven by D/E (A-) and Rev (B+). A score is a quantitative screen of Exponent, Inc.'s fundamentals, not personalised financial advice — weigh it against your own time horizon and risk tolerance, and read the risk factors below before acting.
Why does EXPO score 73.7 on Bull Rankings?
The quality-growth score blends three pillars — quality (returns on capital, margins, leverage, earnings quality), growth (revenue and earnings expansion), and value (valuation versus sector peers). EXPO earns its highest marks on D/E (A-) and Rev (B+). Each pillar is graded against sector-aware thresholds, then combined into the single 0–100 score.
Is EXPO overvalued or undervalued?
Based on $70.21, EXPO sits about 25% above our discounted-cash-flow fair value — the current price implies roughly 14% annual free-cash-flow growth over the next decade. It trades at a 31.5x P/E (graded B). Discounted-cash-flow estimates are sensitive to growth and discount-rate assumptions, so treat this as a cross-check, not a price target.
What are the main risks of investing in EXPO?
The bear case is that EXPO's P/E of 29.7x and PEG of 2.03 embed optimism that 7.8% revenue growth can sustain 12% FCF growth for a decade — a bet on unrelenting demand for niche engineering services. Skeptics point to its 0.28 debt-to-equity as a sign of balance-sheet prudence masking cyclical exposure to construction and automotive end-markets, where downturns could crater utilization. The concrete signal to sell: if revenue growth decelerates below 5% while margins compress below 15%, the model's implied growth assumption breaks and the premium multiple collapses.
Bull Rankings is an automated fundamentals screen for research and education. It is not investment advice, and nothing here is a recommendation to buy or sell any security. Do your own research and consider consulting a licensed financial advisor.